Track Ambu A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Ambu A/S AMBU-B.CO Open Ambu A/S in new tab

86.95 DKK
P/E
38.14
EPS
2.28
Yield
0.47%
P/B
3.84
ROE
10.47
Beta
1.54
Target Price
115.59 DKK
Loading chart...
Key Metrics
Earnings dateAug. 26, 2026
P/E38.14
EPS2.28
Book Value22.64
Price to Book3.84
Debt/Equity9.06
% Insiders41.208%
Growth
Revenue Growth0.06%
Estimates
Forward P/E28.89
Forward EPS3.01
Target Mean Price115.59
Dividend
Dividend Yield0.47%
Annual dividends0.41 DKK
Ex-Div. DateDec. 4, 2025
Payout16.67%
5y avg Yield0.24%

DCF Valuation

Tweak assumptions to recompute fair value for Ambu A/S (AMBU-B.CO)
Currency: DKK
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Ambu A/S Logo Ambu A/S Analysis (AMBU-B.CO)

Denmark Health Care Official Website Stock

Is Ambu A/S a good investment? Ambu A/S (AMBU-B.CO) is currently trading at 86.95 DKK. Market analysts have a consensus price target of 115.59 DKK. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 38.14. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Ambu A/S is expected to release its next earnings report on Aug. 26, 2026. The market consensus estimate for Forward EPS is 3.01.

For income investors, Ambu A/S pays a dividend yield of 0.47%. With a payout ratio of 17%, the dividend appears sustainable.

Investor FAQ

Does Ambu A/S pay a dividend?

Yes, it pays an annual dividend of 0.41 DKK (0.47% yield).

What asset class is Ambu A/S?

Ambu A/S is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 26, 2026. The company currently has a trailing EPS of 2.28.

Company Profile

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Exchange Ticker
CPH (Denmark) AMBU-B.CO
PNK (United States) AMBFF
Dividend Yield

0.47% (5y avg: 0.24%)

Annual Dividends

0.41 DKK

Next ex. div date

Dec. 4, 2025

Payout Ratio

16.67%

Historical Dividends
Year Total Dividends
2026 0.41 DKK
2025 0.41 DKK
2024 0.38 DKK
2021 0.29 DKK
2020 0.29 DKK
2019 0.38 DKK
2018 0.40 DKK
2017 1.85 DKK
2016 1.55 DKK
2015 0.95 DKK
2014 3.75 DKK
2013 1.25 DKK
2012 3.00 DKK
2011 2.00 DKK
2010 2.50 DKK
2009 1.50 DKK
2008 1.50 DKK
2007 1.50 DKK
2006 2.50 DKK
2005 2.00 DKK

Yearly aggregated dividends

Dividends

Ambu A/S
Dec 08, 2025 Paid
Dividend
0.41 DKK

Historical Split Corporate Actions

Split Date Split Ratio to 1
March 1, 2005 2.000000
Dec. 23, 2014 4.000000
Jan. 3, 2018 5.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion